Scalper1 News
Amgen (AMGN) was up more than 5%, near 129, in early trading in the stock market today as analysts approved of big-cap biotech’s earnings beat and restructuring plans announced late Tuesday. Earlier, Amgen stock touched a new high above 131. Amgen’s Q2 earnings beat consensus by nearly 15%, rising 25% over the year-earlier quarter to $2.37 a share. Sales climbed 11% to $5.18 billion, some $300 million above estimates. The company raised its Scalper1 News
Scalper1 News